5 Oral selective tyrosine kinase 2 (TYK2) inhibition with BMS-986165 in patients with systemic lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study (PAISLEY)Shalabh Singhal, Joan T. Merrill, Chris Crater et al.|Abstracts|2019Cited by 3